Hudson Edge Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-400
Closed -$35.7K 116
2024
Q4
$35.7K Hold
400
0.01% 153
2024
Q3
$33.5K Hold
400
0.01% 166
2024
Q2
$30.8K Buy
+400
New +$29.3K 0.01% 163
2021
Q2
Sell
-5,387
Closed -$208K 137
2021
Q1
$208K Sell
5,387
-111,308
-95% -$4.21M 0.07% 132
2020
Q4
$4.2M Buy
116,695
+20,685
+22% +$746K 1.5% 31
2020
Q3
$3.67M Sell
96,010
-63,864
-40% -$2.46M 1.47% 28
2020
Q2
$5.61M Sell
159,874
-7,448
-4% -$268K 1.81% 17
2020
Q1
$5.46M Buy
167,322
+34,179
+26% +$1.34M 2.07% 13
2019
Q4
$6.02M Buy
133,143
+25,160
+23% +$1.05M 1.58% 38
2019
Q3
$4.39M Sell
107,983
-39,932
-27% -$1.69M 1.23% 49
2019
Q2
$6.36M Buy
+147,915
New +$5.69M 1.85% 18
2019
Q1
Sell
-194,963
Closed -$6.89M 139
2018
Q4
$6.89M Sell
194,963
-39,184
-17% -$1.42M 2.13% 9
2018
Q3
$9.02M Sell
234,147
-1,175
-0.5% -$41K 1.6% 37
2018
Q2
$7.7M Sell
235,322
-267,346
-53% -$8.06M 1.44% 43
2018
Q1
$13.7M Sell
502,668
-17,012
-3% -$462K 2.08% 14
2017
Q4
$12.9M Buy
+519,680
New +$14.3M 1.78% 32

Other funds holding BSX

Hudson Edge Investment Partners's BSX Position: Q1 2025 in Review

Hudson Edge Investment Partners sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 400 shares — an estimated $35.7K sold.

Hudson Edge Investment Partners first reported a position in BSX in Q4 2017 and held it in 16 quarters. The position peaked at $13.7M in Q1 2018. 1,643 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Hudson Edge Investment Partners reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 400 Boston Scientific shares in Q1 2025, an estimated $35.7K.
  • Hudson Edge Investment Partners first reported a position in Boston Scientific in Q4 2017 and held it in 16 quarters.
  • Hudson Edge Investment Partners's Boston Scientific position peaked at $13.7M in Q1 2018.
  • 1,643 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Hudson Edge Investment Partners's 13F filing for Q1 2025, filed 28 Apr 2025.